Cargando…
Fibrates: A Possible Treatment Option for Patients with Abdominal Aortic Aneurysm?
Abdominal aortic aneurysm (AAA) is a life-threatening disease; however, there is no established treatment for patients with AAA. Fibrates are agonists of peroxisome proliferator-activated receptor alpha (PPARα) that are widely used as therapeutic agents to treat patients with hypertriglyceridemia. T...
Autores principales: | Amioka, Naofumi, Miyoshi, Toru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773940/ https://www.ncbi.nlm.nih.gov/pubmed/35053222 http://dx.doi.org/10.3390/biom12010074 |
Ejemplares similares
-
Pemafibrate Prevents Rupture of Angiotensin II-Induced Abdominal Aortic Aneurysms
por: Amioka, Naofumi, et al.
Publicado: (2022) -
Pleiotropic effect of fibrates on senescence and autophagy in osteoarthritis
por: Szychlinska, Marta Anna, et al.
Publicado: (2019) -
Anti-atherogenic effects of fibrates in type 2 diabetes
por: Barter, Philip
Publicado: (2001) -
Anomalous aortic origin of the right coronary artery with functional ischemia determined with fractional flow reserve derived from computed tomography
por: Miki, Takashi, et al.
Publicado: (2018) -
Abdominal aortic aneurysm: Treatment options, image visualizations and follow-up procedures
por: Sun, Zhong-Hua
Publicado: (2012)